Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ⅳ Randomized Clinical Trial of Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer

NCT01199432 is registered in ClinicalTrials.gov with Tao OUYANG as lead sponsor.

NCT NCT01199432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01199432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ⅳ Randomized Clinical Trial of Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer
Lead sponsor
Tao OUYANG
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2010
Completion date
December 31, 2014
Enrollment
501 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer